BBarclays XXPeng · XPEV

Barclays Lowers XPeng Price Target to $16

Mar 23, 2026· 1 min read· Reproduced verbatim
Rating
Sell
Price target
$16
Previous
$17
Implied downside
-9%

Barclays analyst Jiong Shao lowered the price target on XPeng (NYSE: XPEV) to $16.00 (from $17.00) while maintaining a Underweight rating.

“Summary: Q1 delivery guide is a bit below our expectations but the company is launching several new models in 2026.

The issue we see is that ’26 is shaping up as a pretty difficult year for NEVs in China as the government is cutting back on tax incentives and a number of EV makers are launching new models.

While management is hopeful and optimistic about the sales of their new models, visibility into success of these new models is limited, needless to say.

The only bright spot we see for Chinese EV makers is the overseas market and we agree with XPEV management that the company should focus on growing its overseas sales by over 100% in ’26 (to over 20% of total vehicle sales).

Separately, the company has been aggressively investing in robotaxi and humanoid robots and has some aspirational year-end targets for both new initiatives.

We are a bit concerned about both the company’s resources and management stretching itself a bit too thin when investing in multiple new areas.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.